Kora Healthcare currently markets directly in United Kingdom, Republic of Ireland, Germany and Sweden. For further information about additional territories, please see the country specific information displayed below.

Outside of these markets Kora Healthcare has well-established partnerships in a number of territories such as the USA, Canada, Australia, New Zealand, South Africa, Saudi Arabia, United Arab Emirates, Kuwait, Oman, Bahrain,  Egypt, Turkey, Sweden, Norway, Finland, Denmark, Malta, Slovenia, Serbia, Croatia, Bosnia-Herzegovina and Montenegro, Thailand, Vietnam, Indonesia and Singapore.

Kora Healthcare is seeking to expandg its product range within our therapeutic areas of Sexual Health, Clinical Nutrition, Infectious Disease and Point of Care rapid result tests. Similarily, Kora Healthcare is seeking to expand into new territories and provide new customers with new product opportunities. To discuss any potential partnership opportunity for a particular territory or region, please contact Conor O’Daly at or alternatively Kora Healthcare would be pleased to meet with you and discuss partnering opportunities at upcoming pharmaceutical events.